1515
Annons
Medicover: Year-end report January-December 2020
Fourth quarter
  • Revenue amounted to €297.7m (€229.7m), an increase of 29.6% with an organic growth of 26.6%.
  • Operating profit (EBIT) was €29.9m (€10.8m), representing an operating margin of 10.1% (4.7%).
  • Net profit amounted to €18.8m (€6.6m), which represents a net profit margin of 6.3% (2.9%).
  • EBITDA was €53.1m (€33.4m), an increase of 59.1%. EBITDA margin was 17.8% (14.5%).
  • EBITDAaL amounted to €41.2m (€22.3m), corresponding to an EBITDAaL margin of 13.9% (9.7%).
  • Net cash flow from operating activities was €40.4m (€25.0m).
  • Basic/diluted earnings per share were €0.123 (€0.048).
  • Covid-19 had a positive financial impact on operating performance.

 

Full year
  • Revenue amounted to €997.8m (€844.4m), an increase of 18.2% with an organic growth of 11.3%.
  • Operating profit (EBIT) was €61.3m (€46.5m), an increase of 32.1%, representing an operating margin of 6.1% (5.5%).
  • Net profit amounted to €27.3m (€24.7m), which represents a net profit margin of 2.7% (2.9%).
  • EBITDA was €157.5m (€120.7m), an increase of 30.6%. EBITDA margin was 15.8% (14.3%).
  • EBITDAaL amounted to €108.5m (€80.6m), an increase of 34.7% corresponding to an EBITDAaL margin of 10.9% (9.5%).
  • Net cash flow from operating activities was €156.0m (€87.3m).
  • Basic/diluted earnings per share were €0.182 (€0.168).
  • Directed share issue of 15 million shares completed in June 2020, net proceeds of €141.9m.
  • The board of directors proposes a dividend for 2020 of €0.07 per share.

 

REVENUE AND EARNINGS

 
€ millions (€m) Q4 2020 Q4 2019 Growth FY 2020 FY 2019 Growth
Revenue 297.7 229.7 30% 997.8 844.4 18%
Operating profit 29.9 10.8 178% 61.3 46.5 32%
(EBIT)
Operating profit 10.1% 4.7% 6.1% 5.5%
margin
Net profit 18.8 6.6 185% 27.3 24.7 11%
Net profit margin 6.3% 2.9% 2.7% 2.9%
Basic/diluted 0.123 0.048 156% 0.182 0.168 8%
earnings per
share, €

EBITDA 53.1 33.4 59% 157.5 120.7 31%
EBITDA margin 17.8% 14.5% 15.8% 14.3%
EBITDAaL 41.2 22.3 85% 108.5 80.6 35%
EBITDAaL margin 13.9% 9.7% 10.9% 9.5%
EBITA 32.7 13.9 135% 76.9 53.7 43%
EBITA margin 11.0% 6.0% 7.7% 6.4%

Definition and reconciliation of alternative performance measures are available at www.medicover.com/financial-information

 

This report has not been subject to review by the Company's auditor.

This is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication through the agency of the contact person set out below at 7.45 (CET) on 12 February 2021. This year-end report and other information about Medicover is available at medicover.com (http://www.medicover.com).

 

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations
Phone: +46 70 303 32 72
E-mail: hanna.bjellquist@medicover.com

Conference call: A conference call for analysts and investors will be held today at 09.30 CET. To listen in please register here (https://edge.media-server.com/mmc/p/86z2u2wt). To ask questions please dial in and use code: 4585621
SE: 08-566 184 67
DE: +49 (0) 305 200 2085
UK: +44 (0) 2071 928 338
US: +1 646 741 3167

 

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities,laboratories and blood-drawing points and the largest markets are Poland and Germany. In 2019, Medicover had revenue around €844 million and 28,800 employees. For more information, go to www.medicover.com

Source: Cision
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

  • Full tillgång till di.se med nyheter och analyser

  • Tillgång till över 1100 aktiekurser i realtid

  • Dagens industri som e-tidning redan kvällen innan

  • Innehållet i alla Di:s appar, tjänster och nyhetsbrev

3 månader för
197 kr
Spara 1000 kr

Prenumerera

Redan prenumerant?